Weiss Kenneth M
Department of Anthropology and Graduate Program in Genetics, Penn State University, University Park, Pennsylvania 16802.
Am J Hum Biol. 1989;1(3):307-319. doi: 10.1002/ajhb.1310010311.
There is running debate in the gerontological research literature concerning the relationship between causes of mortality and the human lifespan. Much of this debate concerns whether we can, by biomedical intervention in known degenerative diseases, square the human survivorship curve, at a point near some human "maximum lifespan potential" (MLP) This paper examines the concepts of lifespan and MLP and the relationship between the shape of the survivorship curve and the pattern of age-specific mortality from chronic disease. The MLP need only be viewed as a statistical phenomenon whose genetic determination relates to general human metabolism rather than to programmed events occurring at the end of the human lifespan. The available evidence suggests that slowing of underlying senescence processes will not have the desired effects on survivorship, but rather the opposite.
老年学研究文献中存在关于死亡率原因与人类寿命之间关系的持续争论。这场争论大多涉及我们是否能够通过对已知退行性疾病进行生物医学干预,在接近人类“最大寿命潜能”(MLP)的某个点使人类生存曲线变得平缓。本文探讨了寿命和MLP的概念,以及生存曲线形状与慢性病年龄别死亡率模式之间的关系。MLP只需被视为一种统计现象,其遗传决定因素与人类一般新陈代谢相关,而非与人类寿命末期发生的程序性事件相关。现有证据表明,减缓潜在衰老过程对生存情况不会产生预期效果,反而会适得其反。